ACADEMY CAPITAL MANAGEMENT INC/TX - PROVECTUS BIOPHARMACEUTICALS ownership

PROVECTUS BIOPHARMACEUTICALS's ticker is PVCT and the CUSIP is 74373P108. A total of 3 filers reported holding PROVECTUS BIOPHARMACEUTICALS in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ACADEMY CAPITAL MANAGEMENT INC/TX ownership history of PROVECTUS BIOPHARMACEUTICALS
ValueSharesWeighting
Q3 2023$1,690
-25.3%
20,0000.0%0.00%
Q2 2023$2,261
+75266.7%
20,0000.0%0.00%
-100.0%
Q1 2023$3
-99.9%
20,0000.0%0.00%
Q4 2022$2,166
+116.6%
20,0000.0%0.00%
Q3 2022$1,0000.0%20,0000.0%0.00%
Q2 2022$1,0000.0%20,0000.0%0.00%
Q1 2022$1,0000.0%20,0000.0%0.00%
Q4 2021$1,0000.0%20,0000.0%0.00%
Q3 2021$1,0000.0%20,0000.0%0.00%
Q2 2021$1,0000.0%20,0000.0%0.00%
Q1 2021$1,0000.0%20,0000.0%0.00%
Q4 2020$1,0000.0%20,0000.0%0.00%
Q3 2020$1,0000.0%20,0000.0%0.00%
Q1 2020$1,0000.0%20,0000.0%0.00%
Q4 2019$1,0000.0%20,0000.0%0.00%
Q3 2019$1,0000.0%20,0000.0%0.00%
Q2 2019$1,0000.0%20,0000.0%0.00%
Q1 2019$1,0000.0%20,0000.0%0.00%
Q4 2018$1,0000.0%20,0000.0%0.00%
Q3 2018$1,0000.0%20,0000.0%0.00%
Q1 2018$1,0000.0%20,0000.0%0.00%
Q4 2017$1,00020,0000.0%0.00%
Q3 2017$0
-100.0%
20,0000.0%0.00%
Q3 2016$1,000
-83.3%
20,0000.0%0.00%
-100.0%
Q2 2016$6,000
-14.3%
20,0000.0%0.00%0.0%
Q1 2016$7,000
-58.8%
20,0000.0%0.00%
-33.3%
Q2 2014$17,000
-65.3%
20,0000.0%0.00%
-70.0%
Q1 2014$49,00020,0000.01%
Other shareholders
PROVECTUS BIOPHARMACEUTICALS shareholders Q4 2019
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 2,226,961$221,0000.02%
HOME FEDERAL BANK OF TENNESSEE 100,000$10,0000.01%
SABBY MANAGEMENT, LLC 1,077,555$107,0000.00%
Cutter & CO Brokerage, Inc. 79,500$8,0000.00%
Virtu KCG Holdings LLC 364,520$36,0000.00%
Tower Research Capital LLC (TRC) 81,647$8,0000.00%
WADE G W & INC 80,000$8,0000.00%
PRINCETON CAPITAL MANAGEMENT LLC 10,000$1,0000.00%
BANK OF AMERICA CORP /DE/ 29,358$3,0000.00%
WELLS FARGO & COMPANY/MN 4,500$00.00%
View complete list of PROVECTUS BIOPHARMACEUTICALS shareholders